EUVIMEDEUVIMED entdecken
Kohortenstudie

Treatment Patterns, Outcomes, and Persistence to Newly Started Heart Failure Medications in Patients with Worsening Heart Failure: A Cohort Study from the United States and Germany

Alexander Michel, Coralie Lecomte, Christoph Ohlmeier, Hanaya Raad, Frederike Basedow, Dennis Haeckl, Dominik Beier, Thomas Evers

American Journal of Cardiovascular Drugs · 2024

DOI: 10.1007/s40256-024-00643-7 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift American Journal of Cardiovascular Drugs, 2024. Verfasst von Alexander Michel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Bayer Consumer Care AG, Pharmaceuticals, Peter Merian Straße 84, 4052, Basel, Switzerland. alexander.michel@bayer.com. Hauptthemen laut MEDLINE: Heart Failure. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Bayer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureHumansMaleGermanyFemaleAgedRetrospective StudiesUnited StatesMiddle AgedPatient ReadmissionHospitalizationAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsAged, 80 and overDisease ProgressionCohort StudiesTreatment OutcomeAdrenergic beta-AntagonistsMineralocorticoid Receptor AntagonistsCardiovascular AgentsDrug Monitoring

Substanzen

Angiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsAdrenergic beta-AntagonistsMineralocorticoid Receptor AntagonistsCardiovascular Agents

Autor:innen und Institutionen

  • Bayer Consumer Care AG, Pharmaceuticals, Peter Merian Straße 84, 4052, Basel, Switzerland. alexander.michel@bayer.com.
  • Aetion Inc., New York, USA.
  • Bayer AG, Berlin, Germany.
  • InGef-Institute for Applied Health Research, Berlin GmbH, Berlin, Germany.
  • WIG2 GmbH, Leipzig, Germany.
  • Bayer AG, Wuppertal, Germany.

Förderung

  • Bayer

Zitieren

APA

Michel, A., Lecomte, C., Ohlmeier, C., Raad, H., Basedow, F., Haeckl, D., Beier, D., & Evers, T. (2024). Treatment Patterns, Outcomes, and Persistence to Newly Started Heart Failure Medications in Patients with Worsening Heart Failure: A Cohort Study from the United States and Germany. American Journal of Cardiovascular Drugs. https://doi.org/10.1007/s40256-024-00643-7

Vancouver

Michel A, Lecomte C, Ohlmeier C, Raad H, Basedow F, Haeckl D, et al. Treatment Patterns, Outcomes, and Persistence to Newly Started Heart Failure Medications in Patients with Worsening Heart Failure: A Cohort Study from the United States and Germany. American Journal of Cardiovascular Drugs. 2024. doi:10.1007/s40256-024-00643-7

BibTeX
@article{Michel2024,
  author = {Michel, Alexander and Lecomte, Coralie and Ohlmeier, Christoph and Raad, Hanaya and Basedow, Frederike and Haeckl, Dennis and Beier, Dominik and Evers, Thomas},
  title = {Treatment Patterns, Outcomes, and Persistence to Newly Started Heart Failure Medications in Patients with Worsening Heart Failure: A Cohort Study from the United States and Germany},
  journal = {American Journal of Cardiovascular Drugs},
  year = {2024},
  doi = {10.1007/s40256-024-00643-7}
}
Kostenlos starten →